n-3 fatty acid deficiency decreases phosphatidylserine accumulation selectively in neuronal tissues

被引:106
|
作者
Hamilton, J [1 ]
Greiner, R [1 ]
Salem, N [1 ]
Kim, HY [1 ]
机构
[1] NIAAA, LMBB, Sect Mass Spectrometry, NIH, Rockville, MD 20852 USA
关键词
D O I
10.1007/S11745-000-0595-x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We have previously shown that the docosahexaenoate (22:6n-3) status in membrane phospholipids influences the biosynthesis and accumulation of phosphatidylserine (PS) in brain microsomes and C6 glioma cells. In the present study, we investigated whether the observed effect of membrane docosahexaenoic acid status on PS accumulation is universal or occurs specifically in neuronal tissues. We observed that rat brain cortex, brain mitochondria, and olfactory bulb, where 22.6n-3 is highly concentrated, contain significantly higher levels of PS in comparison to liver and adrenal, where 22:6n-3 is a rather minor component. Phospholipid molecular species analysis revealed that in brain cortex, mitochondria, and olfactory bulb 18:0,22:6n-3 was the most abundant species representing 45-65% of total PS. In nonneuronal tissues such as liver and adrenal, 18:0,20:4n-6 was the major PS species. Dietary depiction of n-3 fatty acids during prenatal and postnatal developmental periods decreased the brain 22:6n-3 content by more than 80%, with a concomitant increase in 22:5n-6 in all tissues. Under these conditions, an approximately 30-35% reduction in total PS in rat brain cortex, brain mitochondria, and olfactory bulb was observed, while PS levels in liver and adrenal were unchanged. The observed reduction of PS content in neuronal membranes appears to be due to a dramatic reduction of 18:0,22:6n-3-PS without complete replacement by 18:0,22:5n-6-PS. These results establish that variations in membrane 22:6n-3 fatty acid composition have a profound influence on PS accumulation in neuronal tissues where 22:6n-3 is abundant. These data have implications in neuronal signaling events where PS is believed to play an important role.
引用
收藏
页码:863 / 869
页数:7
相关论文
共 50 条
  • [41] N-3 FATTY-ACID REQUIREMENTS OF THE NEWBORN
    INNIS, SM
    LIPIDS, 1992, 27 (11) : 879 - 885
  • [42] Bioavailability of marine n-3 fatty acid formulations
    Dyerberg, J.
    Madsen, P.
    Moller, J. M.
    Aardestrup, I.
    Schmidt, E. B.
    PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS, 2010, 83 (03): : 137 - 141
  • [43] The future of n-3 polyunsaturated fatty acid therapy
    Davidson, Michael H.
    Benes, Lane B.
    CURRENT OPINION IN LIPIDOLOGY, 2016, 27 (06) : 570 - 578
  • [44] DIETARY-EFFECTS OF N-3 EICOSAPENTAENOIC ACID ON ESSENTIAL FATTY ACID-DEFICIENCY SYMPTOMS OF RATS
    TAKEUCHI, H
    INOUE, J
    YOSHIDA, M
    WAKATAKE, S
    ICHIMURA, Y
    EMA, T
    MURAMATSU, K
    AGRICULTURAL AND BIOLOGICAL CHEMISTRY, 1989, 53 (12): : 3225 - 3232
  • [45] Advances in n-3 polyunsaturated fatty acid nutrition
    Li, Duo
    Wahlqvist, Mark L.
    Sinclair, Andrew J.
    ASIA PACIFIC JOURNAL OF CLINICAL NUTRITION, 2019, 28 (01) : 1 - 5
  • [46] No benefit of n-3 fatty acid supplements in diabetes
    Lim, Gregory B.
    NATURE REVIEWS CARDIOLOGY, 2018, 15 (11) : 654 - 654
  • [47] Sex hormones and n-3 fatty acid metabolism
    Childs, Caroline E.
    PROCEEDINGS OF THE NUTRITION SOCIETY, 2020, 79 (02) : 219 - 224
  • [48] n-3 Fatty acid fortification:: opportunities and obstacles
    Harris, William S.
    BRITISH JOURNAL OF NUTRITION, 2007, 97 (04) : 593 - 595
  • [49] n-3 Fatty Acid Intake and Periodontal Disease
    Kaye, Elizabeth Krall
    JOURNAL OF THE AMERICAN DIETETIC ASSOCIATION, 2010, 110 (11) : 1650 - 1652
  • [50] No benefit of n-3 fatty acid supplements in diabetes
    Gregory B. Lim
    Nature Reviews Cardiology, 2018, 15 : 654 - 654